{"id":34307,"date":"2025-12-23T17:58:50","date_gmt":"2025-12-23T16:58:50","guid":{"rendered":"https:\/\/tirzepatyd.eu\/?post_type=product&p=34307"},"modified":"2026-04-12T12:06:53","modified_gmt":"2026-04-12T10:06:53","slug":"tesofensin","status":"publish","type":"product","link":"https:\/\/tirzepatyd.eu\/cs\/obchod-produkt\/tesofensin\/","title":{"rendered":"Tesofensin 500 mcg 30 kapsl\u00ed"},"content":{"rendered":"
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Tesofensin - co to je a jak to funguje<\/h2>

Tesofensin je n\u00edzkomolekul\u00e1rn\u00ed slou\u010denina, kter\u00e1 ovliv\u0148uje neurotransmisi v centr\u00e1ln\u00ed nervov\u00e9 soustav\u011b a je popisov\u00e1na jako inhibitor zp\u011btn\u00e9ho vychyt\u00e1v\u00e1n\u00ed monoamin\u016f (serotoninu, noradrenalinu a dopaminu). V klinick\u00fdch studi\u00edch obezity byl mechanismus \u00fa\u010dinku na sn\u00ed\u017een\u00ed hmotnosti spojen p\u0159edev\u0161\u00edm se sn\u00ed\u017een\u00edm chuti k j\u00eddlu a sn\u00ed\u017een\u00edm spont\u00e1nn\u00edho p\u0159\u00edjmu energie, nikoli s klasick\u00fdm \u201etermogenn\u00edm\u201d zv\u00fd\u0161en\u00edm. V randomizovan\u00e9 studii f\u00e1ze 2 u ob\u00e9zn\u00edch osob vedl tesofensin jako dopln\u011bk stravy k v\u00fdznamn\u011b v\u011bt\u0161\u00edmu \u00fabytku hmotnosti a zlep\u0161en\u00ed parametr\u016f t\u011blesn\u00e9ho slo\u017een\u00ed ve srovn\u00e1n\u00ed s placebem.<\/p>

Pod\u00edvejte se tak\u00e9 na SLU-PP-332 500mcg\/60caps<\/a><\/p>

Tesofensin - stav studie a d\u00e1vkov\u00e1n\u00ed<\/h3>

Tesofensin nem\u00e1 v\u0161eobecn\u011b p\u0159ijat\u00e9, schv\u00e1len\u00e9 d\u00e1vkov\u00e1n\u00ed pro l\u00e9\u010dbu obezity (indikace a regula\u010dn\u00ed status z\u00e1vis\u00ed na zemi a v\u00fdvoj v tomto sm\u011bru byl v minulosti omezen mimo jin\u00e9 bezpe\u010dnostn\u00edmi ot\u00e1zkami). \u00dadaje o d\u00e1vkov\u00e1n\u00ed poch\u00e1zej\u00ed p\u0159edev\u0161\u00edm z klinick\u00fdch studi\u00ed, v nich\u017e bylo hodnoceno n\u011bkolik \u00farovn\u00ed d\u00e1vek. V klasick\u00e9 studii f\u00e1ze 2 byly pou\u017eity d\u00e1vky 0,25 mg, 0,5 mg a 1,0 mg jednou denn\u011b<\/strong> v kombinaci s hypokalorickou dietou, p\u0159i\u010dem\u017e se sleduje vztah mezi d\u00e1vkou a \u00fa\u010dinkem pro sn\u00ed\u017een\u00ed hmotnosti. Jedn\u00e1 se v\u0161ak o v\u00fdzkumn\u00e9 d\u00e1vky z klinick\u00e9ho protokolu, nikoliv o doporu\u010den\u00ed pro vlastn\u00ed u\u017e\u00edv\u00e1n\u00ed.<\/p>

Tesofensin a sni\u017eov\u00e1n\u00ed hmotnosti - v\u00fdsledky studie<\/h3>

Ve studii f\u00e1ze 2 bylo po 24 t\u00fddnech pr\u016fm\u011brn\u00e9 sn\u00ed\u017een\u00ed hmotnosti (p\u0159i %) vy\u0161\u0161\u00ed ve skupin\u00e1ch s tesofensinem ne\u017e ve skupin\u00e1ch s placebem a \u00fa\u010dinek se zvy\u0161oval s d\u00e1vkou. Auto\u0159i rovn\u011b\u017e uvedli, \u017ee \u00fabytek hmotnosti byl do zna\u010dn\u00e9 m\u00edry spojen s \u00fabytkem tuku a zlep\u0161en\u00edm vybran\u00fdch ukazatel\u016f kvality \u017eivota, co\u017e podporuje hypot\u00e9zu o dominantn\u00ed \u201echu\u0165 k j\u00eddlu potla\u010duj\u00edc\u00ed\u201d slo\u017ece \u00fa\u010dinku.<\/p>

Tesofensin - vedlej\u0161\u00ed \u00fa\u010dinky a bezpe\u010dnost podle v\u011bdeck\u00e9 literatury<\/h3>

Mezi nej\u010dast\u011bji hl\u00e1\u0161en\u00e9 ne\u017e\u00e1douc\u00ed \u00fa\u010dinky ve studii obezity pat\u0159ilo sucho v \u00fastech, nevolnost, z\u00e1cpa\/pr\u016fjem a nespavost. V koment\u00e1\u0159\u00edch a diskus\u00edch byl rovn\u011b\u017e zd\u016frazn\u011bn potenci\u00e1ln\u00ed probl\u00e9m zv\u00fd\u0161en\u00e9ho krevn\u00edho tlaku a srde\u010dn\u00ed frekvence, kter\u00fd je d\u016fle\u017eit\u00fd pro posouzen\u00ed kardiovaskul\u00e1rn\u00edho rizika a je obvykle kl\u00ed\u010dovou sou\u010d\u00e1st\u00ed diskus\u00ed o dal\u0161\u00edm v\u00fdvoji t\u011bchto terapi\u00ed.<\/p>

Tesofensin - tr\u017en\u00ed cena a dostupnost\u00a0<\/h3>

Tesofensin nefunguje v EU (N\u011bmecko, \u010cesk\u00e1 republika, Rakousko) ani ve Velk\u00e9 Brit\u00e1nii jako standardn\u00ed l\u00e9k\u00e1rna na sn\u00ed\u017een\u00ed hmotnosti, tak\u017ee pro tuto indikaci neexistuje jednotn\u00e1 \u201el\u00e9k\u00e1rensk\u00e1 cena\u201d. Internetov\u00e9 nab\u00eddky objevuj\u00edc\u00ed se mimo re\u017eim registrovan\u00fdch l\u00e9\u010div\u00fdch p\u0159\u00edpravk\u016f nejsou spolehlivou referenc\u00ed pro cenu l\u00e9\u010dby, proto\u017ee se t\u00fdkaj\u00ed neregulovan\u00e9ho marketingu a nemus\u00ed spl\u0148ovat po\u017eadavky na kvalitu, kter\u00e9 jsou vlastn\u00ed l\u00e9\u010div\u00fdm p\u0159\u00edpravk\u016fm. (P\u0159i popisu SEO je nejbezpe\u010dn\u011bj\u0161\u00ed dr\u017eet se regula\u010dn\u00edho statusu a v\u011bdeck\u00fdch publikac\u00ed).<\/p>

Tesofensine - kde si mohu koupit?<\/strong><\/h3>

Tesofensin je v sou\u010dasn\u00e9 dob\u011b zkoumanou l\u00e1tkou a nem\u00e1 status registrovan\u00e9ho l\u00e9\u010div\u00e9ho p\u0159\u00edpravku pro l\u00e9\u010dbu obezity na evropsk\u00fdch trz\u00edch. Proto nen\u00ed dostupn\u00fd v l\u00e9k\u00e1rn\u00e1ch ani v b\u011b\u017en\u00e9m l\u00e9k\u00e1rensk\u00e9m obchod\u011b.<\/p>

Tesofensin je dostupn\u00fd pouze v r\u00e1mci klinick\u00fdch studi\u00ed a v\u00fdzkumn\u00fdch a v\u00fdvojov\u00fdch projekt\u016f a prost\u0159ednictv\u00edm specializovan\u00fdch dodavatel\u016f, kte\u0159\u00ed jej nab\u00edzej\u00ed jako v\u00fdzkumn\u00e9 \u010dinidlo pro v\u011bdeck\u00e9 a analytick\u00e9 \u00fa\u010dely. L\u00e1tka nen\u00ed ur\u010dena k pou\u017eit\u00ed u lid\u00ed ani k terapeutick\u00fdm \u00fa\u010del\u016fm.<\/p>

\"TESOFENSINE<\/a><\/p>

Zdroje:<\/strong><\/p>

  1. The Lancet (2008) - randomizovan\u00e1 studie f\u00e1ze 2 u obezity (\u00fa\u010dinnost, d\u00e1vky 0,25\/0,5\/1,0 mg, vedlej\u0161\u00ed \u00fa\u010dinky): https:\/\/www.thelancet.com\/journals\/lancet\/article\/PIIS0140-6736%2808%2961525-1\/abstract<\/a><\/p><\/li>

  2. PubMed - Z\u00e1znam studie Astrup et al. (metadata + abstrakt): https:\/\/pubmed.ncbi.nlm.nih.gov\/18950853<\/a><\/p><\/li>

  3. The Lancet (2009) - koment\u00e1\u0159 k profilu (v\u010detn\u011b pom\u011bru tlaku a srde\u010dn\u00ed frekvence): https:\/\/www.thelancet.com\/journals\/lancet\/article\/PIIS0140-6736%2809%2960432-3\/fulltext<\/a><\/p><\/li>

  4. Nature Reviews Drug Discovery (2008) - diskuse o v\u00fdsledc\u00edch a souvislostech: https:\/\/www.nature.com\/articles\/nrd2772<\/a><\/p><\/li><\/ol>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"

    Tesofensin je dob\u0159e zn\u00e1m\u00e1 molekula, kter\u00e1 ovliv\u0148uje centr\u00e1ln\u00ed mechanismy regulace chuti k j\u00eddlu. Jeho \u00fa\u010dinek se zam\u011b\u0159uje na omezen\u00ed p\u0159\u00edjmu energie a podporu kontroly hmotnosti ovlivn\u011bn\u00edm nervov\u00e9ho syst\u00e9mu.<\/p>","protected":false},"featured_media":34004,"comment_status":"open","ping_status":"closed","template":"","meta":{"_acf_changed":false},"product_brand":[],"product_cat":[130,135,15],"product_tag":[137],"class_list":{"0":"post-34307","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-produkty-w-kapsulkach-tabletkach","7":"product_cat-produkty-w-kapsulkach","8":"product_cat-laboratory-research","9":"product_tag-kapsulki","11":"first","12":"instock","13":"sale","14":"shipping-taxable","15":"purchasable","16":"product-type-simple"},"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/tirzepatyd.eu\/cs\/wp-json\/wp\/v2\/product\/34307","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tirzepatyd.eu\/cs\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/tirzepatyd.eu\/cs\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/tirzepatyd.eu\/cs\/wp-json\/wp\/v2\/comments?post=34307"}],"version-history":[{"count":10,"href":"https:\/\/tirzepatyd.eu\/cs\/wp-json\/wp\/v2\/product\/34307\/revisions"}],"predecessor-version":[{"id":35358,"href":"https:\/\/tirzepatyd.eu\/cs\/wp-json\/wp\/v2\/product\/34307\/revisions\/35358"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tirzepatyd.eu\/cs\/wp-json\/wp\/v2\/media\/34004"}],"wp:attachment":[{"href":"https:\/\/tirzepatyd.eu\/cs\/wp-json\/wp\/v2\/media?parent=34307"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/tirzepatyd.eu\/cs\/wp-json\/wp\/v2\/product_brand?post=34307"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/tirzepatyd.eu\/cs\/wp-json\/wp\/v2\/product_cat?post=34307"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/tirzepatyd.eu\/cs\/wp-json\/wp\/v2\/product_tag?post=34307"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}